Ghost Tree Capital as of June 30, 2019
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 42 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sarepta Therapeutics (SRPT) | 9.2 | $44M | 290k | 151.95 | |
| Spdr Series Trust S&p Biotech Put Option (XBI) | 8.4 | $40M | 500k | 80.00 | |
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 7.6 | $36M | 200k | 180.00 | |
| Blueprint Medicines (BPMC) | 7.4 | $35M | 375k | 94.33 | |
| Mirati Therapeutics | 7.2 | $35M | 335k | 103.00 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 5.4 | $26M | 225k | 115.15 | |
| Axsome Therapeutics (AXSM) | 4.6 | $22M | 850k | 25.75 | |
| ACADIA Pharmaceuticals (ACAD) | 4.2 | $20M | 750k | 26.73 | |
| Immunomedics | 4.1 | $19M | 1.4M | 13.87 | |
| Amicus Therapeutics (FOLD) | 3.8 | $18M | 1.5M | 12.48 | |
| Global Blood Therapeutics In | 3.3 | $16M | 300k | 52.60 | |
| Argenx Se Sponsored Adr (ARGX) | 3.0 | $14M | 100k | 141.58 | |
| Alnylam Pharmaceuticals (ALNY) | 2.3 | $11M | 150k | 72.56 | |
| BioCryst Pharmaceuticals (BCRX) | 2.0 | $9.5M | 2.5M | 3.79 | |
| Ra Pharmaceuticals | 1.9 | $9.0M | 300k | 30.07 | |
| Invesco Curncyshs Swiss Fran Swiss Franc (FXF) | 1.8 | $8.8M | 92k | 94.91 | |
| Cymabay Therapeutics | 1.5 | $7.2M | 1.0M | 7.16 | |
| Rocket Pharmaceuticals (RCKT) | 1.4 | $6.9M | 460k | 15.00 | |
| Kalvista Pharmaceuticals (KALV) | 1.4 | $6.6M | 300k | 22.15 | |
| Viewray (VRAYQ) | 1.4 | $6.6M | 750k | 8.81 | |
| Milestone Pharmaceuticals (MIST) | 1.4 | $6.5M | 240k | 27.15 | |
| Momenta Pharmaceuticals | 1.3 | $6.2M | 500k | 12.45 | |
| Pfizer Put Option (PFE) | 1.3 | $6.2M | 150k | 41.00 | |
| Zymeworks | 1.3 | $6.1M | 275k | 22.00 | |
| Epizyme | 1.2 | $5.8M | 465k | 12.55 | |
| Sage Therapeutics (SAGE) | 1.2 | $5.5M | 30k | 183.10 | |
| Spark Therapeutics | 1.1 | $5.1M | 50k | 102.38 | |
| Arvinas Ord (ARVN) | 1.0 | $4.9M | 225k | 21.99 | |
| Biohaven Pharmaceutical Holding | 0.9 | $4.4M | 100k | 43.79 | |
| Kadmon Hldgs | 0.9 | $4.3M | 2.1M | 2.06 | |
| Coherus Biosciences (CHRS) | 0.8 | $3.9M | 175k | 22.10 | |
| Dicerna Pharmaceuticals | 0.8 | $3.7M | 235k | 15.75 | |
| Iovance Biotherapeutics (IOVA) | 0.8 | $3.7M | 150k | 24.52 | |
| Orchard Therapeutics Ads | 0.7 | $3.4M | 243k | 13.99 | |
| Chiasma | 0.6 | $3.0M | 400k | 7.47 | |
| Uniqure Nv SHS (QURE) | 0.6 | $2.7M | 35k | 78.14 | |
| Homology Medicines | 0.5 | $2.4M | 125k | 19.57 | |
| Protagonist Therapeutics (PTGX) | 0.5 | $2.4M | 200k | 12.11 | |
| Odonate Therapeutics Ord | 0.5 | $2.4M | 65k | 36.69 | |
| ArQule | 0.5 | $2.2M | 200k | 11.01 | |
| Solid Biosciences | 0.1 | $575k | 100k | 5.75 | |
| Allakos (ALLK) | 0.1 | $455k | 11k | 43.33 |
